Natural killer cell engagers for cancer immunotherapy

Natural killer cell engagers for cancer immunotherapy

This review article explores the rapidly evolving field of bi-, tri-, and multi-specific NK cell engagers (NKCEs), highlighting their potential as a cutting-edge approach in cancer immunotherapy. NKCEs offer a significant advancement over conventional monoclonal antibodies (mAbs) by enhancing Antibo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shahryar Khoshtinat Nikkhoi, Geng Li, Arash Hatefi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Oncology
Subjects:	NKCE platform technologies NK activating receptors bispecific trispecific multispecific antibodies CD16a NKG2D NKG2C NKp30 NKp46 cancer immunotherapy natural killer cells (NK cells)
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1483884/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers
by: Ammelie Svea Boje, et al.
Published: (2024-12-01)

CD94-driven in vitro expansion of highly functional adaptive NKG2C+ NKG2A- CD57+ NK cells from CMV+ healthy donors
by: Chiara Giordano, et al.
Published: (2025-01-01)

Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis
by: Daciana C. Dumut, et al.
Published: (2025-02-01)

Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with <i>M. bovis</i> BCG or Other Therapies
by: Inmaculada Ruiz-Lorente, et al.
Published: (2025-01-01)

Agonistic anti-NKG2D antibody structure reveals unique stoichiometry and epitope compared to natural ligands
by: Daniel Fallon, et al.
Published: (2024-12-01)

Prognostic significance of perioperative circulating CD56bright NK cell and recovery of NK cell activity in patients with colorectal cancer undergoing radical surgery
by: Jeng-Fu You, et al.
Published: (2025-02-01)

<i>shp-2</i> gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
by: V. G. Subrakova, et al.
Published: (2020-03-01)

Persistent NK cell deficiency associated with pulmonary cryptococcosis
by: Martin Martinot, et al.
Published: (2025-01-01)

Primary extranodal NK/T cell lymphoma of stomach: A case report and review of literature
by: Prashant Mane, et al.
Published: (2024-04-01)

Primary extranodal NK/T cell lymphoma of stomach: A case report and review of literature
by: Prashant Mane, et al.
Published: (2023-07-01)

Changes in immune status of circulating NK cells in patients with latent tuberculosis infection
by: Shuang Qin, et al.
Published: (2024-08-01)

Natural killer cells occupy unique spatial neighborhoods in HER2- and HER2+ human breast cancers
by: Femke A. I. Ehlers, et al.
Published: (2025-01-01)

The molecular receptor NKBB enhances the persistence and anti-hepatocellular carcinoma activity of GPC3 CAR-T cells
by: Minghao Sui, et al.
Published: (2025-02-01)

Resveratrol contributes to NK cell-mediated breast cancer cytotoxicity by upregulating ULBP2 through miR-17-5p downmodulation and activation of MINK1/JNK/c-Jun signaling
by: Bisha Ding, et al.
Published: (2025-02-01)

Extranodal natural killer/T cell lymphoma nasal type simulating osteoradionecrosis with metachronic B lymphoma in the pelvis: Case report
by: Frida S. Colín-Guadarrama, et al.
Published: (2022-11-01)

Markers of immunosenescence in CMV seropositive healthy elderly adults
by: Ivón Johanna Rodríguez, et al.
Published: (2025-01-01)

Antitumor effects of natural killer cells derived from gene-engineered human-induced pluripotent stem cells on hepatocellular carcinoma
by: Mayuna Nakamura, et al.
Published: (2025-02-01)

Application of adoptive cell therapy in malignant melanoma
by: Qianrong Hu, et al.
Published: (2025-01-01)

Interleukin 15‐Presenting Nanovesicles with Doxorubicin‐Loaded Ferritin Cores for Cancer Immunochemotherapy
by: Yihui Zhai, et al.
Published: (2025-01-01)

Transcription factor KLF2 is associated with the dysfunctional status of NK cells and the prognosis of pediatric B-ALL patients
by: Fang Wu, et al.
Published: (2025-01-01)

Increased Chemokine Production is a Hallmark of Rhesus Macaque Natural Killer Cells Mediating Robust Anti-HIV Envelope-Specific Antibody-Dependent Cell-Mediated Cytotoxicity
by: Junsuke Nohara, et al.
Published: (2025-01-01)

Natural Killer Cell-Secreted IFN-γ and TNF-α Mediated Differentiation in Lung Stem-like Tumors, Leading to the Susceptibility of the Tumors to Chemotherapeutic Drugs
by: Kawaljit Kaur, et al.
Published: (2025-01-01)

Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions
by: Michael Mullin, et al.
Published: (2024-12-01)

LLT1 overexpression renders allogeneic-NK resistance and facilitates the generation of enhanced universal CAR-T cells
by: Shuxian Zhu, et al.
Published: (2025-01-01)

CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma
by: Laura M. Moser, et al.
Published: (2025-02-01)

Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR
by: Pui Yeng Lam, et al.
Published: (2025-01-01)

Identification of novel anti-CD16a antibody clones for the development of effective natural killer cell engagers
by: Bill Liao, et al.
Published: (2024-12-01)

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
by: Antonino Glaviano, et al.
Published: (2025-01-01)

MiR-216a-3p inhibits the cytotoxicity of primary natural killer cells
by: Rowan Abdelbary, et al.
Published: (2025-01-01)

Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases
by: Shih-Wen Huang, et al.
Published: (2025-01-01)

Contradictory Effect of Lymphocyte Therapy and Prednisolone Therapy on CD3+CD8+CD56+ Natural Killer T Population in Women with Recurrent Spontaneous Abortion
by: Fatemeh Rezayat, et al.
Published: (2023-07-01)

Changes in PD-1 expression on T lymphocyte subsets and related immune indicators before and after definitive chemoradiotherapy for esophageal squamous cell carcinoma
by: Xueling Shi, et al.
Published: (2025-12-01)

Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy
by: Dewen Zhan, et al.
Published: (2025-01-01)

Hyperbolic Metric Spaces and Stochastic Embeddings
by: Chris Gartland
Published: (2025-01-01)

Survival and prognostic factors for primary lung extranodal NK/T-cell lymphoma: a retrospective study of data from China and the SEER database
by: Qiuyu Li, et al.
Published: (2025-01-01)

Revealing the role of natural killer cells in ankylosing spondylitis: identifying diagnostic biomarkers and therapeutic targets
by: Yuling Chen, et al.
Published: (2025-12-01)

Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy
by: Amelia C. McCue, et al.
Published: (2024-12-01)

Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma
by: Yuxiang Huang, et al.
Published: (2025-01-01)

Interventional factors influencing natural killer cell immunity in colorectal cancer: a systematic review
by: Wai Sinn Soh, et al.
Published: (2025-02-01)

Single-cell RNA sequencing highlights the role of distinct natural killer subsets in sporadic amyotrophic lateral sclerosis
by: Esther Álvarez-Sánchez, et al.
Published: (2025-01-01)